Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.

Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.

<h4>Background</h4>The optimal timing of initiating oral anticoagulants after reperfusion therapy for ischemic stroke is unknown. Factors related to early initiation of rivaroxaban and differences in clinical outcomes of stroke patients with nonvalvular atrial fibrillation (NVAF) who und...

詳細記述

書誌詳細
主要な著者: Junpei Koge, Hiroshi Yamagami, Kazunori Toyoda, Masahiro Yasaka, Teruyuki Hirano, Toshimitsu Hamasaki, Takehiko Nagao, Shinichi Yoshimura, Masahito Fujishige, Akira Tempaku, Shinichiro Uchiyama, Etsuro Mori, Masatoshi Koga, Kazuo Minematsu
フォーマット: 論文
言語:English
出版事項: Public Library of Science (PLoS) 2022-01-01
シリーズ:PLoS ONE
オンライン･アクセス:https://doi.org/10.1371/journal.pone.0264760

インターネット

https://doi.org/10.1371/journal.pone.0264760

類似資料